Phase 1b/2a Study of Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal Cancer or Gastric Cancer

Conditions:   Metastatic Colorectal Cancer;   Gastric Cancer;   Gastroesophageal Junction Adenocarcinoma
Intervention:   Drug: TEW-7197
Sponsors:   MedPacto, Inc.;   Merck Sharp & Dohme Corp.
Not yet recruiting

https://ift.tt/2Dd8NdZ